Title : Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication.

Pub. Date : 2022 Jun 1

PMID : 35467582






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication. Lenalidomide LOC105243590 Mus musculus